NIH/National Institute of Allergies and Infectious Disease (NIAID) is part of the National Institute of Health, funded through theUSA Department of Health and Human Services, a cabinet level agency. NIAID has been in existence for over 50 years and its primary role is to conduct, support and find effective treatments for infectioius, immunological and allergic diseases. Some of its efforts are conducted in-house, but a significant amount of research funds are awarded to scientists, labs and universities to accomplish NIAID goals. NIAID credits itself with developing new vaccines, new therapies and new diagnostic tests which have aided millions of people.
Some content from Wikipedia, licensed under CC BY-SA
Subscribe to rss feed
Lung autopsy and plasma samples from people who died of COVID-19 have provided a clearer picture of how the SARS-CoV-2 virus spreads and damages lung tissue. Scientists at the National Institutes of Health and their collaborators ...
Nov 17, 2021
0
419
An experimental treatment for eczema that aims to modify the skin microbiome safely reduced disease severity and increased quality of life for children as young as 3 years of age, a National Institutes of Health study has ...
Sep 9, 2020
0
870
The virus that causes coronavirus disease 2019 (COVID-19) is stable for several hours to days in aerosols and on surfaces, according to a new study from National Institutes of Health, CDC, UCLA and Princeton University scientists ...
Mar 17, 2020
5
5880
New research supported by the National Institutes of Health delineates how two relatively common variations in a gene called KIF3A are responsible for an impaired skin barrier that allows increased water loss from the skin, ...
Aug 14, 2020
1
338
A new study from National Institutes of Health scientists and their Thai colleagues shows that a "good" bacterium commonly found in probiotic digestive supplements helps eliminate Staphylococcus aureus, a type of bacteria ...
Oct 10, 2018
0
1220
Numerous potential anti-malarial candidate drugs have been uncovered by investigators from the National Institute of Allergy and Infectious Diseases (NIAID) and the National Human Genome Research Institute (NHGRI), both parts ...
Aug 4, 2011
0
0
Topical treatment with live Roseomonas mucosa—a bacterium naturally present on the skin—was safe for adults and children with atopic dermatitis (eczema) and was associated with reduced disease severity, according to initial ...
May 3, 2018
0
532
Atopic dermatitis, a common inflammatory skin condition also known as allergic eczema, affects nearly 20 percent of children, 30 percent of whom also have food allergies. Scientists have now found that children with both ...
Feb 20, 2019
0
811
Scientists at the National Institutes of Health (NIH) have created a protein that awakens resting immune cells infected with HIV and facilitates their destruction in laboratory studies. The protein potentially could contribute ...
Oct 20, 2015
0
2657
In a study of an all-oral drug regimen, a majority of volunteers with liver damage due to hepatitis C virus (HCV) infection were cured following a six-month course of therapy that combined an experimental drug, sofosbuvir, ...
Aug 27, 2013
0
0
